3Q23 Revenues Report: Bioton Sees a 12% YoY Decline, Driven by Insulin Sales Drop of 18%FOREXGPW’s Analytical Coverage Support Programme 3.0
Bioton's 3Q23 Financial Performance: Below Expectations with Production Downtime ImpactFOREXGPW’s Analytical Coverage Support Programme 3.0
Challenges and Opportunities: Bioton's 3Q23 Earnings Forecast Amidst Evolving Market DynamicsFOREXGPW’s Analytical Coverage Support Programme 3.0
WSE: Bioton – (Last valuation: 5.34 PLN/share as of 20.04.2023)STOCKSGPW’s Analytical Coverage Support Programme 3.0
15:20 16.07Dollar Rebounds on CPI Surprise as Services Inflation Stalls BoE and CZK Eyes Further Gains
15:11 16.07OPEC Gradually Unwinds Cuts as Oil Faces Dollar Pressure; Metals and Agriculture Show Mixed Signals
